MIA:
- WHO ATC First Level (Anatomical main group) ID: J ANTIINFECTIVES FOR SYSTEMIC USE
- WHO ATC Second Level (Therapeutic subgroup) ID: J05 ANTIVIRALS FOR SYSTEMIC USE
- WHO ATC Third Level (Pharmacological subgroup) ID: J05A DIRECT ACTING ANTIVIRALS
- WHO ATC Fourth Level (Chemical subgroup) ID: J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
- WHO ATC Fifth Level (Chemical substance) ID: J05AB14 Valganciclovir
- Chemical Name: Valganciclovir', 'DB01004 name: Ganciclovir
- Chemical Smi: OCC(OCn1cnc2c1[nH]c(N)nc2=O)COC(=O)[C@H](C(C)C)N', 'DB01004 smi: OCC(OCn1cnc2c1[nH]c(N)nc2=O)CO
- WHO ICD Mapped Level : G05.1 G05.1 Name: Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
- WHO ICD Fourth Level ID: G05.1 G05.1 Name: Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
- WHO ICD Third Level ID: G05 G05 Name: Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere
- WHO ICD Second Level ID: G00-G09 G00-G09 Name: Inflammatory diseases of the central nervous system
- WHO ICD First Level ID: VI VI Name: Diseases of the nervous system
|
|